Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best biotech stocks to buy. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) participated in the Bank of America Global Healthcare Conference 2025 on September 23. During the conference, the company presented a strategic review of its robust pipeline, encompassing both encouraging advancements and possible barriers. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported that it has five phase 3 initiatives in progress and is focusing ...